Finexio Closes $35 Million Series B Funding Round
24 oct. 2022 08h00 HE
|
Finexio
ORLANDO, Fla., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Finexio, the fast-growing B2B accounts payables (AP) Payments-as-a-Service company, today announces the successful completion of an oversubscribed...
Otonomo to Present at J.P. Morgan Automotive Conference in NYC
26 juil. 2022 08h00 HE
|
OTONOMO TECHNOLOGIES LTD
HERZLIYA, Israel and SAN FRANCISCO, July 26, 2022 (GLOBE NEWSWIRE) -- Otonomo Technologies Ltd. (Nasdaq: OTMO), the platform powering the mobility economy, today announced that Ben Volkow will...
AFR Furniture Rental Closes on Recapitalization Transaction in Conjunction With J.P. Morgan Global Alternatives
10 janv. 2022 13h00 HE
|
AFR Furniture Rental
PENNSAUKEN, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- AFR Furniture Rental is proud to announce a recapitalization transaction in conjunction with the Global Special Situations team of J.P. Morgan...
Coherus and Junshi Biosciences Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
10 janv. 2022 07h30 HE
|
Coherus BioSciences, Inc.
• Coherus and Junshi Biosciences plan to evaluate the toripalimab + JS006 combinationin clinical trials in multiple tumor types • Combinations of PD-1 + TIGIT inhibitors have potential to expand...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
09 janv. 2022 18h00 HE
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
Morphic Therapeutic to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
05 janv. 2022 08h00 HE
|
Morphic Therapeutic
WALTHAM, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious...
BioNTech präsentiert auf der 40. Annual J.P. Morgan Healthcare Conference
27 déc. 2021 06h45 HE
|
BioNTech SE
MAINZ, Deutschland, 27. Dezember 2021 — BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, dass CEO und Mitbegründer Prof. Dr. Ugur Sahin ein Unternehmensupdate auf der...
BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference
27 déc. 2021 06h45 HE
|
BioNTech SE
MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview and update at...
Micron Technology Announces Upcoming Investor Event
14 déc. 2021 16h01 HE
|
Micron Technology, Inc.
BOISE, Idaho, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced Chief Financial Officer David Zinsner will take part in a fireside chat at the J.P. Morgan...
J.P. Morgan Goes Live With Proxymity's Digital Proxy Voting Platform
26 oct. 2021 04h00 HE
|
Proxymity
LONDON, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Proxymity, the pioneering investor communication platform backed by a consortium of the some of the world's largest global custodians, today announced that...